Literature DB >> 6344993

The methodologic dilemma in retrospectively correlating the amount of chemotherapy received in adjuvant therapy protocols with disease-free survival.

C Redmond, B Fisher, H S Wieand.   

Abstract

Mesh:

Substances:

Year:  1983        PMID: 6344993

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN: 0361-5960


× No keyword cloud information.
  7 in total

1.  Statistics and ethics in medical research.

Authors:  David L DeMets
Journal:  Sci Eng Ethics       Date:  1999-01       Impact factor: 3.525

2.  Factors causing dose variability in drug administration.

Authors:  R Demicheli; A Jirillo; G Bonciarelli; F Lonardi; M Pradella; M Balli
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

3.  Adjuvant chemotherapy in postmenopausal women: results of sequential noncross-resistant regimens.

Authors:  C Brambilla; A Rossi; P Valagussa; G Bonadonna
Journal:  World J Surg       Date:  1985-10       Impact factor: 3.352

4.  Reduced recurrence-free survival after reduced doses of adjuvant chemotherapy in breast cancer: are groups selected after randomization comparable?

Authors:  L E Rutqvist; A Wallgren; A C Wennerholm
Journal:  Breast Cancer Res Treat       Date:  1986       Impact factor: 4.872

Review 5.  Dose intensity in cancer chemotherapy.

Authors:  D J Dodwell; H Gurney; N Thatcher
Journal:  Br J Cancer       Date:  1990-06       Impact factor: 7.640

6.  Haematological toxicity: a marker of adjuvant chemotherapy efficacy in stage II and III breast cancer.

Authors:  T Saarto; C Blomqvist; P Rissanen; A Auvinen; I Elomaa
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

7.  Leucocyte nadir as a marker for chemotherapy efficacy in node-positive breast cancer treated with adjuvant CMF.

Authors:  P Poikonen; T Saarto; J Lundin; H Joensuu; C Blomqvist
Journal:  Br J Cancer       Date:  1999-08       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.